Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Oxford Nanopore Technologies Ltd.

Latest From Oxford Nanopore Technologies Ltd.

The Inexorable Rise Of Exscientia

The UK firm has not completed a clinical trial yet but having raised over $350m from its NASDAQ initial public offering and an extra $160m from a private placement, Exscientia's future looks extremely bright.

Financing Artificial Intelligence

Stock Watch: Reading The Tea Leaves For Pharma Q1 Earnings

Contrasting first-quarter preannouncements from a DNA sequencing company and a molecular diagnostics company may, with other seasonal pressures, imply a comparatively weak first quarter for therapeutic drug companies.

Stock Watch Sales & Earnings

UK Orders 450K POC Tests For COVID-19, First Diagnostic From Oxford Nanopore

The LamPORE assay will also be used to test for the winter influenza virus.

United Kingdom Coronavirus COVID-19

UK Still Looking For The Magic Bullet To Reach COVID-19 Testing Goals

Viral testing of swabs using PCR to confirm COVID-19 in individuals continues to be the main thrust of the UK’s coronavirus control efforts as it targets 100,000 and more tests a day. PCR alternatives and antibody testing will come into the picture more in the coming weeks.

United Kingdom Coronavirus COVID-19
See All

Company Information

  • Industry
  • Research, Analytical Equipment & Supplies
  • Biotechnology
    • Nanotechnology, Chips, etc.
  • Other Names / Subsidiaries
    • Oxford NanoLabs Ltd
    • STS Diagnostics.